Simon Lambden

Simon Lambden is an accomplished Executive Medical Director at AstraZeneca, leading translational medicine across clinical development, particularly in rare cardiovascular and metabolic programs. As an Expert with Primary Venture Partners, Simon provides strategic guidance within a top-tier seed-stage firm. Previously, Simon served as Chief Medical Officer at Inotrem SA, overseeing the exploration of the TREM-1 pathway for inflammatory diseases. Simon has a strong academic background, with a Doctor of Medicine from the University of London, a PhD in Vascular Biology from Imperial College London, and certifications from Harvard Medical School. Additional roles include Founding Director positions at LKBD Consulting Limited and Critical Pressure Limited, as well as a Consultant in Intensive Care Medicine at Cambridge University Hospitals NHS Foundation Trust.